John Kwon

Array ( [id] => 4779416 [patent_doc_number] => 20080287414 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-20 [patent_title] => 'Mitotic Kinesin Inhibitors' [patent_app_type] => utility [patent_app_number] => 11/630231 [patent_app_country] => US [patent_app_date] => 2005-06-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31595 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0287/20080287414.pdf [firstpage_image] =>[orig_patent_app_number] => 11630231 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 281838 [patent_doc_number] => 07553838 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-06-30 [patent_title] => 'Mitotic kinesin inhibitors' [patent_app_type] => utility [patent_app_number] => 11/630302 [patent_app_country] => US [patent_app_date] => 2005-06-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18052 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/553/07553838.pdf [firstpage_image] =>[orig_patent_app_number] => 11630302 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4792722 [patent_doc_number] => 20080293696 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-27 [patent_title] => '2-Aminoarylcarboxamides Useful as Cancer Chemotherapeutic Agents' [patent_app_type] => utility [patent_app_number] => 11/630850 [patent_app_country] => US [patent_app_date] => 2005-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 42522 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0293/20080293696.pdf [firstpage_image] =>[orig_patent_app_number] => 11630850 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4658081 [patent_doc_number] => 20080026943 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-01-31 [patent_title] => 'Phenyl-Substituted [1,2]-Oxazine-3,5-Dione and Dihydropyrone Derivatives' [patent_app_type] => utility [patent_app_number] => 11/631656 [patent_app_country] => US [patent_app_date] => 2005-06-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22663 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0026/20080026943.pdf [firstpage_image] =>[orig_patent_app_number] => 11631656 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6926519 [patent_doc_number] => 20050239775 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-27 [patent_title] => 'Substituted-3-indolyl-4-piperidino-alkyl heterocycles for the treatment of depression' [patent_app_type] => utility [patent_app_number] => 11/158875 [patent_app_country] => US [patent_app_date] => 2005-06-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10012 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0239/20050239775.pdf [firstpage_image] =>[orig_patent_app_number] => 11158875 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7233564 [patent_doc_number] => 20050256108 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-17 [patent_title] => 'Spiroazacyclic compounds as monoamine receptor modulators' [patent_app_type] => utility [patent_app_number] => 11/154083 [patent_app_country] => US [patent_app_date] => 2005-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 22695 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0256/20050256108.pdf [firstpage_image] =>[orig_patent_app_number] => 11154083 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7070138 [patent_doc_number] => 20050245523 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-03 [patent_title] => 'Heteroaryl derivatives and their use as medicaments' [patent_app_type] => utility [patent_app_number] => 11/152599 [patent_app_country] => US [patent_app_date] => 2005-06-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7174 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0245/20050245523.pdf [firstpage_image] =>[orig_patent_app_number] => 11152599 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 880128 [patent_doc_number] => 07354917 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-04-08 [patent_title] => 'Oxabispidine compounds and their use in the treatment of cardiac arrhythmias' [patent_app_type] => utility [patent_app_number] => 11/570439 [patent_app_country] => US [patent_app_date] => 2005-06-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26809 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/354/07354917.pdf [firstpage_image] =>[orig_patent_app_number] => 11570439 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 185161 [patent_doc_number] => 07648985 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-01-19 [patent_title] => 'Oxabispidine compounds and their use in the treatment of cardiac arrhythmias' [patent_app_type] => utility [patent_app_number] => 11/570451 [patent_app_country] => US [patent_app_date] => 2005-06-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 37382 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/648/07648985.pdf [firstpage_image] =>[orig_patent_app_number] => 11570451 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 432329 [patent_doc_number] => 07265102 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-09-04 [patent_title] => 'Substituted pyrazoles' [patent_app_type] => utility [patent_app_number] => 11/147923 [patent_app_country] => US [patent_app_date] => 2005-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27601 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/265/07265102.pdf [firstpage_image] =>[orig_patent_app_number] => 11147923 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 463845 [patent_doc_number] => 07238710 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-07-03 [patent_title] => 'EP4 receptor agonist, compositions and methods thereof' [patent_app_type] => utility [patent_app_number] => 11/146992 [patent_app_country] => US [patent_app_date] => 2005-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18707 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/238/07238710.pdf [firstpage_image] =>[orig_patent_app_number] => 11146992 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7251746 [patent_doc_number] => 20050272929 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-08 [patent_title] => 'Crystalline polymorphs of (3S)-N-hydroxy-4-({4-[(4-hydroxy-2-butynul)oxy]phenyl}sulfonyl)-2,2-dimethyl-3-thiomorpholine carboxamide' [patent_app_type] => utility [patent_app_number] => 11/146730 [patent_app_country] => US [patent_app_date] => 2005-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 6845 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0272/20050272929.pdf [firstpage_image] =>[orig_patent_app_number] => 11146730 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 533136 [patent_doc_number] => 07179911 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-02-20 [patent_title] => 'Method for preparing hydroxamic acids' [patent_app_type] => utility [patent_app_number] => 11/146723 [patent_app_country] => US [patent_app_date] => 2005-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5744 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/179/07179911.pdf [firstpage_image] =>[orig_patent_app_number] => 11146723 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 535513 [patent_doc_number] => 07173034 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-02-06 [patent_title] => 'Respiratory syncytial virus replication inhibitors' [patent_app_type] => utility [patent_app_number] => 11/144126 [patent_app_country] => US [patent_app_date] => 2005-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30574 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/173/07173034.pdf [firstpage_image] =>[orig_patent_app_number] => 11144126 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 535793 [patent_doc_number] => 07173054 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-02-06 [patent_title] => 'Respiratory syncytial virus replication inhibitors' [patent_app_type] => utility [patent_app_number] => 11/144103 [patent_app_country] => US [patent_app_date] => 2005-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30520 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/173/07173054.pdf [firstpage_image] =>[orig_patent_app_number] => 11144103 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 798027 [patent_doc_number] => 07427614 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-09-23 [patent_title] => 'Prostaglandin analogs' [patent_app_type] => utility [patent_app_number] => 10/552083 [patent_app_country] => US [patent_app_date] => 2005-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6173 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/427/07427614.pdf [firstpage_image] =>[orig_patent_app_number] => 10552083 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 252711 [patent_doc_number] => 07579345 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-08-25 [patent_title] => 'Muscarinic acetylcholine receptor antagonists' [patent_app_type] => utility [patent_app_number] => 11/568909 [patent_app_country] => US [patent_app_date] => 2005-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8189 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/579/07579345.pdf [firstpage_image] =>[orig_patent_app_number] => 11568909 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5739057 [patent_doc_number] => 20060009448 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-12 [patent_title] => 'Metabolites of 4-(3,4-dichloro-phenyl)-2-[2-(4-methyl-piperazin-1-yl)-benzylidene]thiomorpholin-3-one' [patent_app_type] => utility [patent_app_number] => 11/135204 [patent_app_country] => US [patent_app_date] => 2005-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14188 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20060009448.pdf [firstpage_image] =>[orig_patent_app_number] => 11135204 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5591476 [patent_doc_number] => 20060040928 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-23 [patent_title] => 'Method of treating diseases and conditions associated with an altered level of amyloid beta peptides and new enolcarboxamide compounds' [patent_app_type] => utility [patent_app_number] => 11/132815 [patent_app_country] => US [patent_app_date] => 2005-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19809 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0040/20060040928.pdf [firstpage_image] =>[orig_patent_app_number] => 11132815 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 837028 [patent_doc_number] => 07393843 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-07-01 [patent_title] => 'Method of treating diseases and conditions associated with an altered level of amyloid β peptides and new enolcarboxamide compounds' [patent_app_type] => utility [patent_app_number] => 11/132482 [patent_app_country] => US [patent_app_date] => 2005-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19686 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/393/07393843.pdf [firstpage_image] =>[orig_patent_app_number] => 11132482 [rel_patent_id] =>[rel_patent_doc_number] =>)